Terms: = Brain cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Treatment
1556 results:
1. The Father of Wisdom: "The Influence of Surgical Experience on Overall Survival in Patients with Malignant Gliomas".
Florian IS; Beni L; Andrasoni Z; Aldea C; Florian IA
Adv Tech Stand Neurosurg; 2024; 49():181-200. PubMed ID: 38700685
[TBL] [Abstract] [Full Text] [Related]
2. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
[No Abstract] [Full Text] [Related]
3. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
[TBL] [Abstract] [Full Text] [Related]
4. Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer.
Divan HA; Bittoni MA; Krishna A; Carbone DP
BMC Cancer; 2024 Apr; 24(1):424. PubMed ID: 38580900
[TBL] [Abstract] [Full Text] [Related]
5.
Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
[TBL] [Abstract] [Full Text] [Related]
6. An analysis of neutrophil-to-lymphocyte ratios and monocyte-to-lymphocyte ratios with six-month prognosis after cerebral contusions.
Zhang D; Zhuang D; Li T; Liu X; Zhang Z; Zhu L; Tian F; Chen X; Li K; Chen W; Sheng J
Front Immunol; 2024; 15():1336862. PubMed ID: 38545111
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of Patients with Non-Small Cell Lung cancer and brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort.
Nannini S; Guisier F; Curcio H; Ricordel C; Demontrond P; Abdallahoui S; Baloglu S; Greillier L; Chouaid C; Schott R
Curr Oncol; 2024 Mar; 31(3):1656-1666. PubMed ID: 38534959
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
[TBL] [Abstract] [Full Text] [Related]
9. Recurrence Patterns and Surveillance Imaging in Pediatric brain Tumor Survivors.
Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
[TBL] [Abstract] [Full Text] [Related]
10. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
[TBL] [Abstract] [Full Text] [Related]
11. A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate cancer.
Boiarsky D; Gulhan DC; Savignano H; Lakshminarayanan G; McClure HM; Silver R; Hirsch MS; Sholl LM; Choudhury AD; Ananda G; Park PJ; Tewari AK; Berchuck JE
Clin Genitourin Cancer; 2024 Apr; 22(2):558-568.e3. PubMed ID: 38342659
[TBL] [Abstract] [Full Text] [Related]
12. Neoadjuvant Immunotherapy With Ipilimumab Plus Nivolumab in Mismatch Repair Deficient/Microsatellite Instability-High Colorectal cancer: A Preliminary Report of Case Series.
Pan T; Yang H; Wang WY; Rui YY; Deng ZJ; Chen YC; Liu C; Hu H
Clin Colorectal Cancer; 2024 Mar; 23(1):104-110. PubMed ID: 38336555
[TBL] [Abstract] [Full Text] [Related]
13. Porcine-human glioma xenograft model. Immunosuppression and model reproducibility.
Hoopes PJ; Tavakkoli AD; Moodie KA; Maurer KJ; Meehan KR; Wallin DJ; Aulwes E; Duval KEA; Chen KL; -Burney MAC; Li C; Fan X; Evans LT; Paulsen KD
Cancer Treat Res Commun; 2024; 38():100789. PubMed ID: 38262125
[TBL] [Abstract] [Full Text] [Related]
14. Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
Dagher R; Gad M; da Silva de Santana P; Sadeghi MA; Yewedalsew SF; Gujar SK; Yedavalli V; Köhler CA; Khan M; Tavora DGF; Kamson DO; Sair HI; Luna LP
J Neurooncol; 2024 Jan; 166(1):1-15. PubMed ID: 38212574
[TBL] [Abstract] [Full Text] [Related]
15. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
[TBL] [Abstract] [Full Text] [Related]
16. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
17. Deep learning MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers.
Bird D; Speight R; Andersson S; Wingqvist J; Al-Qaisieh B
Radiother Oncol; 2024 Feb; 191():110052. PubMed ID: 38096921
[TBL] [Abstract] [Full Text] [Related]
18. Association of county-level socioeconomic status with meningioma incidence and outcomes.
Pugazenthi S; Price M; De La Vega Gomar R; Kruchko C; Waite KA; Barnholtz-Sloan JS; Walsh KM; Kim AH; Ostrom QT
Neuro Oncol; 2024 Apr; 26(4):749-763. PubMed ID: 38087980
[TBL] [Abstract] [Full Text] [Related]
19. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
Budhu JA; Chukwueke UN; Jackson S; Lee EQ; McFaline-Figueroa JR; Willmarth N; Dalmage M; Kawachi I; Arons D; Chang SM; Galanis E; Hervey-Jumper SL; Wen PY; Porter AB
Neuro Oncol; 2024 Apr; 26(4):596-608. PubMed ID: 38071654
[TBL] [Abstract] [Full Text] [Related]
20. T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.
Behar M; Peck KK; Yildirim O; Tisnado J; Saha A; Arevalo-Perez J; Lis E; Yamada Y; Holodny AI; Karimi S
AJNR Am J Neuroradiol; 2023 Dec; 44(12):1451-1457. PubMed ID: 38049990
[TBL] [Abstract] [Full Text] [Related]
[Next]
